Skip to main content
EuBiologics Co., Ltd. logo

EuBiologics Co., Ltd. — Investor Relations & Filings

Ticker · 206650 ISIN · KR7206650004 KO Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2021-03-17 Annual Report
Country KR South Korea
Listing KO 206650

About EuBiologics Co., Ltd.

http://eubiologics.com/eng/

EuBiologics Co., Ltd. is a biopharmaceutical company focused on improving global public health through the development and supply of safe and effective vaccines. The company specializes in preventative vaccines against global pandemics and emerging infectious diseases, with a key product being its oral cholera vaccine. In addition to its vaccine pipeline, EuBiologics provides Contract Research and Manufacturing Organization (CRMO) services. These services cover the development and GMP-compliant production of mammalian cell and microbial-derived biopharmaceuticals, including protein-based therapeutics and antibodies. The company is committed to technological innovation and adhering to international standards to address global health challenges.

Recent filings

Filing Released Lang Actions
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2020, submitted by EuBiologics Co., Ltd. to the Financial Supervisory Service (FSS) and the Korea Exchange. It contains comprehensive financial statements, management discussion and analysis, governance information, and operational details. This document is the standard Korean regulatory filing equivalent to a 10-K in the US market. FY 2020
2021-03-17 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Eubiologics. It contains the agenda for the Annual General Meeting (AGM), including the approval of financial statements, election of directors, and other corporate governance matters. It also includes management's business report and financial statements as reference materials for shareholders. This document is a standard proxy statement/notice sent to shareholders to inform them of the meeting and solicit their votes, which falls under the Proxy Solicitation & Information Statement category.
2021-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains details about the meeting agenda, director nominations, and financial statements. This falls under the category of Proxy Solicitation & Information Statement (PSI).
2021-03-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the sale of shares by an executive (Hong Ik-pyo) of Eubiologics. This type of filing, which reports personal share transactions by company insiders, is classified as 'Director's Dealing' (DIRS).
2021-03-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a standard Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a mandatory disclosure document filed with the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) when an insider (executive or major shareholder) changes their shareholding position. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider transactions and ownership changes by company directors and executives.
2021-02-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a South Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in Korea when an executive or major shareholder changes their shareholding position. This falls under the category of Director's Dealing (DIRS), as it reports personal share transactions and ownership changes by a company executive.
2021-02-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.